{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:50:19Z","timestamp":1761324619348,"version":"3.40.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,14]]},"DOI":"10.7759\/cureus.82255","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:43:02Z","timestamp":1744659782000},"source":"Crossref","is-referenced-by-count":2,"title":["The Efficacy of Quadruple Therapy Versus Triple Therapy in Helicobacter pylori Eradication"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Barakat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Althahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanin","family":"Aljazaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Hammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Alabbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Alserdieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Abubaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li Y","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023, 8:553-64. 10.1016\/S2468-1253(23)00070-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi JK","year":"2017","unstructured":"Hooi JK, Lai WY, Ng WK, et al.. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017, 153:420-9. 10.1053\/j.gastro.2017.04.022","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31820fb8f6","article-title":"Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline","volume":"45","author":"World Gastroenterology Organisation","year":"2011","unstructured":"World Gastroenterology Organisation. Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline. J Gastrointestin Liver Dis. 2011, 45:383-8. 10.1097\/MCG.0b013e31820fb8f6","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194215","article-title":"Association between dietary habits and Helicobacter pylori infection among Bahraini adults","volume":"14","author":"Habbash F","year":"2022","unstructured":"Habbash F, Alalwan TA, Perna S, et al.. Association between dietary habits and Helicobacter pylori infection among Bahraini adults. Nutrients. 2022, 14:10.3390\/nu14194215","journal-title":"Nutrients"},{"key":"ref5","article-title":"The association between Helicobacter pylori infection and lymphoid reaction in patients suffering from dyspepsia in Bahrain","volume":"5","author":"Fakhro AR","year":"1999","unstructured":"Fakhro AR. The association between Helicobacter pylori infection and lymphoid reaction in patients suffering from dyspepsia in Bahrain. Saudi J Gastroenterol. 1999, 5:129-33.","journal-title":"Saudi J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner P","year":"2017","unstructured":"Malfertheiner P, Megraud F, O'Morain CA, et al.. Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report. Gut. 2017, 66:6-30. 10.1136\/gutjnl-2016-312288","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613015","article-title":"Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review","volume":"110","author":"Hopkins RJ","year":"1996","unstructured":"Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996, 110:1244-52. 10.1053\/gast.1996.v110.pm8613015","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study","volume":"158","author":"Kumar S","year":"2020","unstructured":"Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study. Gastroenterology. 2020, 158:527-36. 10.1053\/j.gastro.2019.10.019","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford AC","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020, 69:2113-21. 10.1136\/gutjnl-2020-320839","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.028","article-title":"Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis","volume":"150","author":"Lee YC","year":"2016","unstructured":"Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016, 150:1113-24. 10.1053\/j.gastro.2016.01.028","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi A","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018, 155:1372-82. 10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"key":"ref12","article-title":"Antibiotic susceptibilities of Helicobacter pylori","volume":"22","author":"Bindayna KM","year":"2001","unstructured":"Bindayna KM. Antibiotic susceptibilities of Helicobacter pylori. Saudi Med J. 2001, 22:53-7.","journal-title":"Saudi Med J"},{"key":"ref13","article-title":"Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline","volume":"20","author":"Hunt RH","year":"2011","unstructured":"Hunt RH, Xiao SD, Megraud F, et al.. Helicobacter pylori in developing countries. World Gastroenterology Organisation global guideline. J Gastrointestin Liver Dis. 2011, 20:299-304.","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.047","article-title":"Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection","volume":"155","author":"Liou JM","year":"2018","unstructured":"Liou JM, Chen PY, Luo JC, et al.. Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection. Gastroenterology. 2018, 155:1109-19. 10.1053\/j.gastro.2018.06.047","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4052","article-title":"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis","volume":"351","author":"Li BZ","year":"2015","unstructured":"Li BZ, Threapleton DE, Wang JY, et al.. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ. 2015, 351:h4052. 10.1136\/bmj.h4052","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham DY","year":"2014","unstructured":"Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014, 12:177-86.e3; Discussion e12-3. 10.1016\/j.cgh.2013.05.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey WD","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017, 112:212-39. 10.1038\/ajg.2016.563","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner P","year":"2012","unstructured":"Malfertheiner P, Megraud F, O'Morain CA, et al.. Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report. Gut. 2012, 61:646-64. 10.1136\/gutjnl-2012-302084","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31409-X","article-title":"Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"388","author":"Liou JM","year":"2016","unstructured":"Liou JM, Fang YJ, Chen CC, et al.. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2016, 388:2355-65. 10.1016\/S0140-6736(16)31409-X","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15761\/ICM.1000129","article-title":"Eradication rate of Helicobacter pylori by classic triple therapy in Lebanon: is it still effective?","author":"Hassan M","year":"2018","unstructured":"Hassan M, Noureddine M, Assi F, Houmani Z. Eradication rate of Helicobacter pylori by classic triple therapy in Lebanon: is it still effective?. Int Clin Med. 2018, 10.15761\/ICM.1000129","journal-title":"Int Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000132","article-title":"Eradication efficacy of modified dual therapy compared with bismuth-containing quadruple therapy as a first-line treatment of Helicobacter pylori","volume":"114","author":"Yang J","year":"2019","unstructured":"Yang J, Zhang Y, Fan L, et al.. Eradication efficacy of modified dual therapy compared with bismuth-containing quadruple therapy as a first-line treatment of Helicobacter pylori. Am J Gastroenterol. 2019, 114:437-45. 10.14309\/ajg.0000000000000132","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_626_19","article-title":"Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia","volume":"26","author":"Alsohaibani F","year":"2020","unstructured":"Alsohaibani F, Alquaiz M, Alkahtani K, Alashgar H, Peedikayil M, AlFadda A, Almadi M. Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia. Saudi J Gastroenterol. 2020, 26:84-8. 10.4103\/sjg.SJG_626_19","journal-title":"Saudi J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_95_20","article-title":"Strategies for Helicobacter pylori eradication in the year 2020","volume":"26","author":"Pellicano R","year":"2020","unstructured":"Pellicano R, Ribaldone DG, Caviglia GP. Strategies for Helicobacter pylori eradication in the year 2020. Saudi J Gastroenterol. 2020, 26:63-5. 10.4103\/sjg.SJG_95_20","journal-title":"Saudi J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.22541\/au.162184164.44494990\/v1","article-title":"Treatment of Helicobacter pylori in the Arab world: a systematic review and network meta-analysis","author":"Shimaa Afify","year":"2021","unstructured":"Shimaa Afify, Muhammad Abdel-Gawad, Eshak Bahbah, et al.. Treatment of Helicobacter pylori in the Arab world: a systematic review and network meta-analysis. Authorea. 2021, 10.22541\/au.162184164.44494990\/v1","journal-title":"Authorea"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21608\/MJCU.2018.56560","article-title":"Effectiveness of different treatment regimens on eradication of Helicobacter pylori infection (a single center experience in Kuwait)","volume":"86","author":"Abd El-Naby HB","year":"2018","unstructured":"Abd El-Naby HB, Abd El-Aleem AM, Al-Hashash WA, Mehrem SS. Effectiveness of different treatment regimens on eradication of Helicobacter pylori infection (a single center experience in Kuwait). Med J Cairo Univ. 2018, 86:1693-7. 10.21608\/MJCU.2018.56560","journal-title":"Med J Cairo Univ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic resistance of Helicobacter pylori among male United States veterans","volume":"13","author":"Shiota S","year":"2015","unstructured":"Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol. 2015, 13:1616-24. 10.1016\/j.cgh.2015.02.005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2015.09.007","article-title":"Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait","volume":"16","author":"Alboraie M","year":"2015","unstructured":"Alboraie M, Saad M, Al-Ali J, Malik M, Asem N, Schmidt I, Alfadhli AA. Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait. Arab J Gastroenterol. 2015, 16:131-5. 10.1016\/j.ajg.2015.09.007","journal-title":"Arab J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.306","article-title":"A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori","volume":"106","author":"Basu PP","year":"2011","unstructured":"Basu PP, Rayapudi K, Pacana T, Shah NJ, Krishnaswamy N, Flynn M. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am J Gastroenterol. 2011, 106:1970-5. 10.1038\/ajg.2011.306","journal-title":"Am J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085620","article-title":"Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials","volume":"9","author":"Peedikayil MC","year":"2014","unstructured":"Peedikayil MC, Alsohaibani FI, Alkhenizan AH. Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials. PLoS One. 2014, 9:85620. 10.1371\/journal.pone.0085620","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2014.887765","article-title":"Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis","volume":"49","author":"Xiao SP","year":"2014","unstructured":"Xiao SP, Gu M, Zhang GX. Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis. Scand J Gastroenterol. 2014, 49:528-538. 10.3109\/00365521.2014.887765","journal-title":"Scand J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_288_22","article-title":"Practice guidelines for the management of Helicobacter pylori infection: the Saudi H. pylori Working Group recommendations","volume":"29","author":"Alsohaibani F","year":"2023","unstructured":"Alsohaibani F, Peedikayil M, Alshahrani A, Somily A, Alsulaiman R, Azzam N, Almadi M. Practice guidelines for the management of Helicobacter pylori infection: the Saudi H. pylori Working Group recommendations. Saudi J Gastroenterol. 2023, 29:326-46. 10.4103\/sjg.sjg_288_22","journal-title":"Saudi J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-014-0450-6","article-title":"Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism","volume":"33","author":"Settin A","year":"2014","unstructured":"Settin A, Abdalla AF, Al-Hussaini AS, El-Baz R, Galal A. Cure rate of Helicobacter pylori infection in Egyptian children related to CYP2C19 gene polymorphism. Indian J Gastroenterol. 2014, 33:330-5. 10.1007\/s12664-014-0450-6","journal-title":"Indian J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.165","article-title":"Treatment of clinically diagnosed laryngopharyngeal reflux disease","volume":"136","author":"Youssef TF","year":"2010","unstructured":"Youssef TF, Ahmed MR. Treatment of clinically diagnosed laryngopharyngeal reflux disease. Arch Otolaryngol Head Neck Surg. 2010, 136:1089-92. 10.1001\/archoto.2010.165","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003879","article-title":"A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: a single center experience","volume":"95","author":"Abd-Elsalam S","year":"2016","unstructured":"Abd-Elsalam S, Kobtan A, El-Kalla F, et al.. A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: a single center experience. Medicine (Baltimore). 2016, 95:e3879. 10.1097\/MD.0000000000003879","journal-title":"Medicine (Baltimore)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2019.09.001","article-title":"Egyptian recommendations for management of Helicobacter pylori infection: 2018 report","volume":"20","author":"Alboraie M","year":"2019","unstructured":"Alboraie M, Elhossary W, Aly OA, et al.. Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. Arab J Gastroenterol. 2019, 20:175-9. 10.1016\/j.ajg.2019.09.001","journal-title":"Arab J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/318918-the-efficacy-of-quadruple-therapy-versus-triple-therapy-in-helicobacter-pylori-eradication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:43:03Z","timestamp":1744659783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/318918-the-efficacy-of-quadruple-therapy-versus-triple-therapy-in-helicobacter-pylori-eradication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.82255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,14]]}}}